Brainstorm Cell Therapeutics Overview

Brainstorm Cell Therapeutics Profit Margin

Profitability ratio analysis for BCLI.

Quarterly Profit Margin

1194.94%

As of Mar 2026

Annual Profit Margin (TTM)

1736.44%

↑ 157.17% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin